Moreover, PDIA6 was also enhanced in imatinib-resistant renal cell carcinoma tissues (n = 24) compared with the imatinib-sensitive renal cell carcinoma tissues (n = 36) (Figure 1(a,b)). This evidence concerns the gene PDIA6 and renal cell carcinoma.